AAAAAA
Results:
1-19
|
Results: 19
Authors:
WARZOCHA K
RIBEIRO P
BIENVENU J
ROY P
CHARLOT C
RIGAL D
COIFFIER B
SALLES G
Citation: K. Warzocha et al., GENETIC POLYMORPHISMS IN THE TUMOR-NECROSIS-FACTOR LOCUS INFLUENCE NON-HODGKINS-LYMPHOMA OUTCOME, Blood, 91(10), 1998, pp. 3574-3581
Authors:
WARZOCHA K
SALLES G
Citation: K. Warzocha et G. Salles, THE TUMOR-NECROSIS-FACTOR SIGNALING COMPLEX - CHOOSING A PATH TOWARD CELL-DEATH OR CELL-PROLIFERATION, Leukemia & lymphoma, 29(1-2), 1998, pp. 81-92
Authors:
WARZOCHA K
RIBEIRO P
BIENVENU J
ROY P
CHARLOT C
COIFFIER B
SALLES G
Citation: K. Warzocha et al., INHERITED SUSCEPTIBILITY FOR INCREASE TNF PRODUCTION IMPAIRS LYMPHOMAPATIENTS OUTCOME, British Journal of Haematology, 102(1), 1998, pp. 144-144
Authors:
WARZOCHA K
BIENVENU J
RIBEIRO P
MOULLET I
DUMONTET C
NEIDHARDTBERARD EM
COIFFIER B
SALLES G
Citation: K. Warzocha et al., PLASMA-LEVELS OF TUMOR-NECROSIS-FACTOR AND ITS SOLUBLE RECEPTORS CORRELATE WITH CLINICAL-FEATURES AND OUTCOME OF HODGKINS-DISEASE PATIENTS, British Journal of Cancer, 77(12), 1998, pp. 2357-2362
Authors:
WARZOCHA K
RIBEIRO P
CHARLOT C
RENARD N
COIFFIER B
SALLES G
Citation: K. Warzocha et al., A NEW DEATH RECEPTOR-3 ISOFORM - EXPRESSION IN HUMAN LYMPHOID-CELL LINES AND NON-HODGKINS-LYMPHOMAS, Biochemical and biophysical research communications, 242(2), 1998, pp. 376-379
ANTISENSE STRATEGY - BIOLOGICAL UTILITY AND PROSPECTS IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
Authors:
WARZOCHA K
WOTOWIEC D
Citation: K. Warzocha et D. Wotowiec, ANTISENSE STRATEGY - BIOLOGICAL UTILITY AND PROSPECTS IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES, Leukemia & lymphoma, 24(3-4), 1997, pp. 267-281
Authors:
WARZOCHA K
FABIANOWSKAMAJEWSKA K
BLONSKI J
KRYKOWSKI E
ROBAK T
Citation: K. Warzocha et al., 2-CHLORODEOXYADENOSINE INHIBITS ACTIVITY OF ADENOSINE-DEAMINASE AND S-ADENOSYLHOMOCYSTEINE HYDROLASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of cancer, 33(1), 1997, pp. 170-173
Authors:
WARZOCHA K
SALLES G
BIENVENU J
BASTION Y
DUMONTET C
RENARD N
NEIDHARDTBERARD EM
COIFFIER B
Citation: K. Warzocha et al., TUMOR-NECROSIS-FACTOR LIGAND-RECEPTOR SYSTEM CAN PREDICT TREATMENT OUTCOME IN LYMPHOMA PATIENTS, Journal of clinical oncology, 15(2), 1997, pp. 499-508
Authors:
WARZOCHA K
BIENVENU J
CHARLOT C
RENARD N
RIBEIRO P
COIFFIER B
SALLES G
Citation: K. Warzocha et al., POLYMORPHIC STRUCTURE OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN-ALPHA LOCI IN NON-HODGKINS-LYMPHOMA PATIENTS, Experimental hematology, 25(8), 1997, pp. 400-400
Authors:
WARZOCHA K
RIBEIRO P
BIENVENU J
ROY P
CHARLOT C
COIFFIER B
SALLES G
Citation: K. Warzocha et al., GENETIC POLYMORPHISMS IN THE TUMOR-NECROSIS-FACTOR REGION INFLUENCE NON-HODGKINS-LYMPHOMA OUTCOME, Blood, 90(10), 1997, pp. 1501-1501
Authors:
WARZOCHA K
RENARD N
CHARLOT C
BIENVENU J
COIFFIER B
SALLES G
Citation: K. Warzocha et al., IDENTIFICATION OF 2 LYMPHOTOXIN-BETA ISOFORMS EXPRESSED IN HUMAN LYMPHOID-CELL LINES AND NON-HODGKINS-LYMPHOMAS, Biochemical and biophysical research communications, 238(2), 1997, pp. 273-276
Authors:
WARZOCHA K
KRYKOWSKI E
GORATYBOR J
FRONCZAK A
ROBAK T
Citation: K. Warzocha et al., FULMINANT 2-CHLORODEOXYADENOSINE-RELATED PERIPHERAL NEUROPATHY IN A PATIENT WITH PARANEOPLASTIC NEUROLOGICAL SYNDROME-ASSOCIATED WITH LYMPHOMA, Leukemia & lymphoma, 21(3-4), 1996, pp. 343-346
Authors:
SALLES G
BIENVENU J
BASTION Y
BARBIER Y
DOCHE C
WARZOCHA K
GUTOWSKI MC
RIEUX C
COIFFIER B
Citation: G. Salles et al., ELEVATED CIRCULATING LEVELS OF TNF-ALPHA AND ITS P55 SOLUBLE RECEPTORARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS, British Journal of Haematology, 93(2), 1996, pp. 352-359
Authors:
WARZOCHA K
RENARD N
CHARLOT C
BIENVENU J
COIFFIER B
SALLES G
Citation: K. Warzocha et al., LYMPHOTOXIN-ALPHA (LT-ALPHA) AND LYMPHOTOXIN-BETA (LT-BETA) GENES EXPRESSION IN TRANSFORMED-CELL LINES AND NON-HODGKINS-LYMPHOMAS - PRESENCE OF AN ALTERNATIVELY SPLICED FORM OF LT-BETA, Blood, 88(10), 1996, pp. 1497-1497
Authors:
WARZOCHA K
RENARD N
CHARLOT C
BIENVENU J
BASTION Y
NEIDHARTBERARD EM
DUMONTET C
COIFFIER B
SALLES G
Citation: K. Warzocha et al., THE TUMOR-NECROSIS-FACTOR, LYMPHOTOXIN AND FAS LIGAND-RECEPTOR SYSTEMGENES EXPRESSION IN NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1498-1498
Authors:
WARZOCHA K
BIENVENU J
COIFFIER B
SALLES G
Citation: K. Warzocha et al., MECHANISMS OF ACTION OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN LIGAND-RECEPTOR SYSTEM, European cytokine network, 6(2), 1995, pp. 83-96
Authors:
GORATYBOR J
WARZOCHA K
ROBAK T
Citation: J. Goratybor et al., THE INFLUENCE OF 2-CHLORODEOXYADENOSINE IN COMBINATION WITH TUMOR-NECROSIS-FACTOR-ALPHA OR ITS MUTEIN ON MURINE LEUKEMIAS L1210 AND P388, Mediators of inflammation, 4(3), 1995, pp. 205-208
Authors:
WARZOCHA K
SALLES G
BIENVENU J
BASTION Y
COIFFIER B
Citation: K. Warzocha et al., HIGH TUMOR-NECROSIS-FACTOR-ALPHA, ITS SOLUBLE RECEPTORS P55 AND P75 BUT NOT LYMPHOTOXIN-ALPHA PLASMA-LEVELS ARE RELATED TO ADVERSE PROGNOSTIC FACTORS AND POOR OUTCOME IN LYMPHOMA PATIENTS, Blood, 86(10), 1995, pp. 2111-2111
Authors:
WARZOCHA K
GORATYBOR J
KWINKOWSKI M
SZYMANSKA B
ROBAK T
Citation: K. Warzocha et al., A COMPARISON OF THE ANTILEUKEMIC EFFECTS OF RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR-ALPHA AND ITS MUTEINS ON LEUKEMIA-L1210 AND LEUKEMIA P388 IN MICE, Mediators of inflammation, 3(6), 1994, pp. 411-414
Risultati:
1-19
|